aphranel® は MXGP Shanghai 2026 と提携し、再生医療の美学を促進します
aphranel®、中国発の再生医療ブランドは、2026 MXGP Shanghaiと提携し、より広範な層に顔面美学技術を紹介することを目的としています。このたび展示されるのは、MagiCCrystal CaHA Biostructurerです。
なぜ重要か. このパートナーシップは、中国の再生医療美学技術がますます国際的に認知されていることを強調しており、その市場拡大の可能性を示しています。
01
根拠
- PPR Newswire news releases企業開示2026-10-09 16:50
MagiCCrystal obtuvo el registro de dispositivo médico de Clase III de la NMPA
- PPR Newswire news releases企業開示2026-10-09 16:50
el producto se distribuye a través de más de 700 clínicas de medicina estética en toda China.
- PPR Newswire news releases企業開示2026-10-09 16:50
Desde que se llevó a cabo su lanzamiento comercial, las ventas acumuladas han superado las 200.000 jeringas
- PPR Newswire news releases企業開示2026-10-09 14:00
the product is distributed through more than 700 medical aesthetics clinics across China.
- PPR Newswire news releases企業開示2026-10-09 14:00
Its MagiCCrystal CaHA Biostructurer is used for anatomy-based facial contouring
- PPR Newswire news releases企業開示2026-10-09 14:00
Since its commercial launch, cumulative sales have exceeded 200,000 syringes
- PPR Newswire news releases企業開示2026-10-09 14:00
aphranel®, a regenerative aesthetics brand developed in China by MOYOM Biotech
- PPR Newswire news releases企業開示2026-10-09 14:00
In February 2025, after 12 years of research and product development, MagiCCrystal received NMPA Class III medical device registration
- PPR Newswire news releases企業開示2026-10-09 14:00
MagiCCrystal received NMPA Class III medical device registration
- PPR Newswire news releases企業開示2026-10-09 16:50
En febrero de 2025, después de llevar a cabo 12 años de investigación y desarrollo de producto, MagiCCrystal obtuvo el registro de dispositivo médico de Clase III de la NMPA
- PPR Newswire news releases企業開示2026-10-09 16:50
Su bioestructurador MagiCCrystal CaHA se utiliza para el contorneado facial basado en la anatomía en zonas como por ejemplo las cejas, la nariz, el mentón y la mandíbula.
- PPR Newswire news releases企業開示2026-10-09 14:00
The collaboration is part of aphranel®'s broader effort to introduce international audiences to regenerative aesthetics technology developed in China. Alongside continued investment in biomaterial research and commercialization, the brand has expanded its initiatives across spor…
- PPR Newswire news releases企業開示2026-10-09 14:00
SHANGHAI, Oct. 9, 2026 /PRNewswire/ -- aphranel®, a regenerative aesthetics brand developed in China by MOYOM Biotech, was an official partner of the 2026 FIM Motocross World Championship (MXGP) Shanghai, held September 11–13. At the event, the brand introduced its approach to f…